{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:46:52Z","timestamp":1789156012051,"version":"build-2803163510"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T00:00:00Z","timestamp":1629676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFD0501300"],"award-info":[{"award-number":["2016YFD0501300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Carbapenems, colistin, and tigecycline are critically important antibiotics in clinics. After the global appearance of <jats:italic>bla<\/jats:italic><jats:sub><jats:italic>NDM<\/jats:italic><\/jats:sub> and <jats:italic>mcr<\/jats:italic> mediating the resistance to carbapenems and colistin, respectively, tigecycline becomes the last-resort drug against severe human infections caused by multidrug-resistant bacteria. Recently, a mobile tigecycline resistance gene <jats:italic>tet<\/jats:italic>(X4) has been identified in <jats:italic>Escherichia coli<\/jats:italic>, <jats:italic>Klebsiella pneumoniae<\/jats:italic>, and <jats:italic>Acinetobacter baumannii<\/jats:italic> that causes high resistance to tigecycline and other tetracyclines. In this study, the prevalence of <jats:italic>tet<\/jats:italic>(X4) in <jats:italic>E. coli<\/jats:italic> isolates from duck and goose farms in Southeast China was identified and characterized.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Feces, soil, sewage, and dust samples were collected from duck and goose farms along with the southeast coast provinces of China. Antimicrobial susceptibility testing and polymerase chain reaction screening were performed to investigate the phenotype and genotype of tigecycline resistance. Conjugation, S1 pulsed-field gel electrophoresis (PFGE), and whole-genome sequencing were used to determine the transferability, genetic location, and the genomic characteristics of <jats:italic>tet<\/jats:italic>(X4).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 1,716 samples were collected, and 16 isolates (0.9%) recovered from Guangdong, Shandong, and Jiangsu were positive for <jats:italic>tet<\/jats:italic>(X4) gene with tigecycline minimum inhibitory concentrations \u226516 mg\/L. Notably, among these <jats:italic>tet<\/jats:italic>(X4)-positive <jats:italic>E. coil<\/jats:italic> isolates, seven of them were from the environment samples (soil and sewage). PFGE and multilocus sequence typing demonstrated that ST3997 was the most prevalent sequence type (eight isolates, 50%) in Jiangsu province. By conjugation assays, 11 isolates were able to transfer <jats:italic>tet<\/jats:italic>(X4) plasmid to <jats:italic>E. coli<\/jats:italic> C600 recipient, and these plasmids belonged to IncHI1 and IncX1 detected by sequence analysis. <jats:italic>tet<\/jats:italic>(X4) was found adjacent to an insertion sequence IS<jats:italic>CR2<\/jats:italic> downstream and a <jats:italic>cat<\/jats:italic>D gene upstream for all isolates. In addition, multiple-drug resistance to tigecycline, chlortetracycline, ampicillin, florfenicol, ciprofloxacin, gentamicin, trimethoprim\/sulfamethoxazole, and fosfomycin was profiled in most of the <jats:italic>tet<\/jats:italic>(X4)-positive isolates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The identification of <jats:italic>tet<\/jats:italic>(X4) harboring <jats:italic>E. coli<\/jats:italic> strains in duck farms and their surrounding environment enlarges our knowledge of the variety and prevalence of tigecycline resistance. The prevalence of <jats:italic>tet<\/jats:italic>(X4) raises concern for the use of tetracyclines in animal farming, and the <jats:italic>tet<\/jats:italic>(X4) gene should be listed as primary gene for resistance surveillance.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2021.716393","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T12:48:11Z","timestamp":1629722891000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Prevalence of tet(X4) in Escherichia coli From Duck Farms in Southeast China"],"prefix":"10.3389","volume":"12","author":[{"given":"Yang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1852","DOI":"10.1128\/AAC.01852-17","article-title":"Mutations at the ribosomal s10 gene in clinical strains of staphylococcus aureus with reduced susceptibility to tigecycline.","volume":"62","author":"Angeles Argudin","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1900340","DOI":"10.2807\/1560-7917.ES.2019.24.25.1900340","article-title":"Detection of plasmid-mediated tigecycline-resistant gene tet(X4) in Escherichia coli from pork, Sichuan and Shandong Provinces, China, February 2019.","volume":"24","author":"Bai","year":"2019","journal-title":"Euro Surveill"},{"key":"B3","year":"2019","journal-title":"Performance Standards for Antimicrobial Susceptibility Testing"},{"key":"B4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fmicb.2018.00648","article-title":"The Rapid Emergence of Tigecycline Resistance in blaKPC\u20132 Harboring Klebsiella pneumoniae, as Mediated in Vivo by Mutation in tetA During Tigecycline Treatment.","volume":"9","author":"Du","year":"2018","journal-title":"Front. Microbiol."},{"key":"B5","year":"2021","journal-title":"European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters, Version 11.0."},{"key":"B6","year":"2013","journal-title":"European Medicines Agency. Tygacil<sup>\u00ae<\/sup> SmPC."},{"key":"B7","first-page":"1","year":"2005","journal-title":"TIGECYCLINE for injection, for intravenous use Initial U.S. Approval: 2005."},{"key":"B8","year":"2019","journal-title":"Tigecycline \u2013 Injection products, FDA-Identified Interpretive Criteria."},{"key":"B9","doi-asserted-by":"publisher","first-page":".e1","DOI":"10.1016\/j.cmi.2019.11.011","article-title":"Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime\/avibactam: epidemiology and genomic characterization.","volume":"26","author":"Gaibani","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1520404","DOI":"10.1155\/2016\/1520404","article-title":"Persistent bacteremia from pseudomonas aeruginosa with in vitro resistance to the novel antibiotics ceftolozane-tazobactam and ceftazidime-avibactam.","volume":"2016","author":"Gangcuangco","year":"2016","journal-title":"Case Rep. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41564-019-0445-2","article-title":"Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans.","volume":"2019","author":"He","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B12","author":"Krag","year":"2015","journal-title":"The State of and Aquaculture World Fisheries."},{"key":"B13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.diagmicrobio.2016.03.009","article-title":"High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand.","volume":"85","author":"Lunha","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/aac.01242-13","article-title":"In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.","volume":"58","author":"Macone","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","author":"Miao","year":"2010","journal-title":"Distribution and characteristics of duck-fish farming systems in eastern china."},{"key":"B16","first-page":"1","author":"Michigan State University","year":"2014","journal-title":"Resistance Breakpoints for Antimicrobials Used in Animals."},{"key":"B17","first-page":"16","article-title":"Highlights at the 28th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2018.","volume":"32","author":"Nabal","year":"2019","journal-title":"Rev. Esp. Quimioter."},{"key":"B18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/mdr.2015.0264","article-title":"Novel E. coli ST5123 Containing blaNDM-1 Carried by IncF Plasmid Isolated from a Pediatric Patient in Serbia.","volume":"22","author":"Novovic","year":"2016","journal-title":"Microb. Drug Resist."},{"key":"B19","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1016\/S0924-8579(09)70005-6","article-title":"A review of tigecycline - the first glycylcycline.","volume":"32","author":"Peterson","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41564-019-0496-4","article-title":"Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli.","volume":"2019","author":"Sun","year":"","journal-title":"Nat. Microbiol."},{"key":"B21","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41564-019-0496-4","article-title":"Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli.","volume":"4","author":"Sun","year":"","journal-title":"Nat. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1093\/nar\/19.24.6823","article-title":"Distribution of repetitive DNA sequences in eubacteria and application to finerpriting of bacterial enomes.","volume":"19","author":"Versalovic","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2217\/fmb-2016-0100","article-title":"Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.","volume":"11","author":"Villano","year":"2016","journal-title":"Future Microbiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"16260","DOI":"10.1038\/nmicrobiol.2016.260","article-title":"Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production.","volume":"2","author":"Wang","year":"2017","journal-title":"Nat. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":".e1","DOI":"10.1016\/j.cmi.2018.06.012","article-title":"Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical Acinetobacter nosocomialis isolate.","volume":"25","author":"Yang","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"B26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/jac\/dky413","article-title":"Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model.","volume":"74","author":"Yu","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6772","DOI":"10.1021\/acs.est.5b00729","article-title":"Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance.","volume":"49","author":"Zhang","year":"2015","journal-title":"Environ. Sci. Technol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.716393\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T12:48:22Z","timestamp":1629722902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.716393\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":28,"alternative-id":["10.3389\/fmicb.2021.716393"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.716393","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]},"article-number":"716393"}}